Back to Journals » OncoTargets and Therapy » Volume 9

Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases

Total article views   HTML views PDF downloads Totals
8,148 Dovepress* 7,572+ 1,453 9,025
PubMed Central* 576 268 844
Totals 8,148 1,721 9,869
*Since 21 April 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar